Stock listing

NASDAQ:TARA Protara Therapeutics, Inc. Stock

Home listing (NASDAQ) of Protara Therapeutics, Inc.

Follow Protara Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:TARA

$2.32 USD -0.08 (-3.3%)

Close on Oct 16, 2026

Protara Therapeutics, Inc. logo
Ticker
NASDAQ:TARA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Protara Therapeutics (NASDAQ:TARA) Q1 2026 Earnings Call

    Tue, May 19, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support

Oct 15, 2026

Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Sep 8, 2026

Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update

Aug 11, 2026

Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

May 20, 2026

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026

May 18, 2026

Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC

May 15, 2026

Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update

May 13, 2026

Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting

Apr 27, 2026

Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

Mar 10, 2026

TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

Feb 23, 2026

All Protara Therapeutics, Inc. news

Decks

Protara Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
26 in the last 12 months · 115 in all · newest Oct 15, 2026 · oldest 2020
Calls
1 call with a replay · 1 with a transcript · latest May 19, 2026
Decks
18 decks · latest August 2026

Where Protara Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:TARA · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:A2P4JELS ExchangeGermanyEUR
gettex:1KPAgettexGermanyEUR
Lang & Schwarz:A2P4JELang & SchwarzGermanyEUR
BOATS:TARABOATSUnited StatesUSD
Tradegate:1KPATradegateGermanyEUR
Dusseldorf:1KPADusseldorfGermanyEUR
Frankfurt:1KPAFrankfurtGermanyEUR
Hamburg:1KPAHamburgGermanyEUR
Munich:1KPAMunichGermanyEUR
Stuttgart:1KPAStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Protara Therapeutics, Inc.